Fingerprint
Dive into the research topics of 'Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from two phase III trials: RISE and RIDE'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically